Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 3
Submit an article Journal homepage
287
Views
5
CrossRef citations to date
0
Altmetric
Letters to the Editor

Allogeneic hematopoietic cell transplant for patients with end stage renal disease requiring dialysis – a single institution experience

Mazyar ShadmanClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; ;Department of Medicine, University of Washington, Seattle, WA, USA;
,
Sangeeta HingoraniClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; ;Department of Pediatrics, University of Washington, Seattle, WA, USA;
,
Scott A. LanumDepartment of Pharmacy, University of Washington, Seattle, WA, USA
,
John M. PagelClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; ;Department of Medicine, University of Washington, Seattle, WA, USA;
,
Rainer StorbClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; ;Department of Medicine, University of Washington, Seattle, WA, USA;
,
David G. MaloneyClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; ;Department of Medicine, University of Washington, Seattle, WA, USA;
&
Brenda M. SandmaierClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; ;Department of Medicine, University of Washington, Seattle, WA, USA; Correspondence[email protected]
 show all
Pages 740-742 | Received 15 Apr 2016, Accepted 27 Jun 2016, Published online: 25 Jul 2016

References

  • Majhail NS, Farnia SH, Carpenter PA. Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2015;21:1863–1869.
  • Baron F, Storb R. Allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning as treatment for hematologic malignancies and inherited blood disorders. Mol Ther. 2006;13:26–41.
  • Niscola P, Vischini G, Tendas A, et al. Management of hematological malignancies in patients affected by renal failure. Expert Rev Anticancer Ther. 2011;11:415–432.
  • Bodge MN, Reddy S, Thompson MS, et al. Preparative regimen dosing for hematopoietic stem cell transplantation in patients with chronic kidney disease: analysis of the literature and recommendations. Biol Blood Marrow Transplant. 2014;20:908–919.
  • Hamaki T, Katori H, Kami M, et al. Successful allogeneic blood stem cell transplantation for aplastic anemia in a patient with renal insufficiency requiring dialysis. Bone Marrow Transplant. 2002;30:195–198.
  • Horwitz ME, Spasojevic I, Morris A, et al. Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics. Biol Blood Marrow Transplant. 2007;13:1422–1426.
  • van Besien K, Schouten V, Parsad S, et al. Allogeneic stem cell transplant in renal failure: engraftment and prolonged survival, but high incidence of neurologic toxicity. Leuk Lymphoma. 2012;53:158–159.
  • Lichtman SM, Etcubanas E, Budman DR, et al. The pharmacokinetics and pharmacodynamics of fludarabine phosphate in patients with renal impairment: a prospective dose adjustment study. Cancer Invest. 2002;20:904–913.
  • Kielstein JT, Stadler M, Czock D, et al. Dialysate concentration and pharmacokinetics of 2F-Ara-A in a patient with acute renal failure. Eur J Haematol. 2005;74:533–534.
  • Haubitz M, Bohnenstengel F, Brunkhorst R, et al. Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency. Kidney Int. 2002;61:1495–1501.
  • Aronoff GR, Bennett WM, Berns JS, et al. Drug prescribing in renal failure: dosing guidelines for adults and children. 5th ed. Philadelphia (PA): American College of Physicians; 2007. pp. 97, 170.
  • Janus N, Thariat J, Boulanger H, et al. Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients. Ann Oncol. 2010;21:1395–1403.
  • Bischoff ME, Blau W, Wagner T, et al. Total body irradiation and cyclophosphamide is a conditioning regimen for unrelated bone marrow transplantation in a patient with chronic myelogenous leukemia and renal failure on hemodialysis. Bone Marrow Transplant. 1998;22:591–593.
  • Perry JJ, Fleming RA, Rocco MV, et al. Administration and pharmacokinetics of high-dose cyclophosphamide with hemodialysis support for allogeneic bone marrow transplantation in acute leukemia and end stage renal disease. Bone Marrow Transplant. 1999;23:839–842.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.